Home > Healthcare > Medical Devices > Rehabilitation and Assistive Devices > Neurorehabilitation Devices Market

Neurorehabilitation Devices Market Trends

Report ID: GMI7702
Published Date: Dec 2023
Report Format: PDF

Download Free Sample

Neurorehabilitation Devices Market Trends

Elevated R&D activities propel the development of innovative neurorehabilitation devices and technique, promising enhanced patient outcomes. Pivotal collaborations among academia, healthcare, and industry foster a multidisciplinary approach in R&D activities to address neurological disorders. This synergy accelerates innovation, grounding emerging technologies in scientific rigor and practical applicability.

For instance, the National Institute of Neurological Disorders and Stroke (NINDS) actively conducts rigorous neuroscience research, spanning basic nervous system function, rehabilitation strategies, clinical trial readiness, and essential needs. These initiatives complement private sector R&D, fostering a holistic advancement in neurological science.
Thus, the collaborative spirit ensures the ongoing research and development of effective, targeted neurorehabilitation solutions, thereby benefiting individuals suffering with neurological impairments.
Furthermore, the escalating recognition among healthcare practitioners, individuals, and those providing care regarding the advantages of rehabilitation equipment serves as a pivotal stimulator.
This heightened awareness results in the prompt adaptation of these devices, enhanced incorporation into rehabilitation initiatives, and elevated patient adherence, thereby exerting a positive influence on the market.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global market size for neurorehabilitation devices was valued at USD 1.9 billion in 2023 and is estimated to reach USD 5.8 billion by 2032 as they are designed to aid in the rehabilitation and recovery of individuals with neurological disorders or injuries.

The neurorobotics segment of neurorehabilitation devices industry garnered USD 604 million in 2023 and will grow significantly through 2032 as these devices enable intensive and repetitive training, promoting neuroplasticity and functional recovery.

The U.S. neurorehabilitation devices market accounted for USD 693 million in 2023 and is predicted to witness substantial growth through 2032 attributed to the country's advanced healthcare infrastructure, a robust R&D landscape, and a high prevalence of neurological disorders.

Bioventus LLC, Ectron Ltd., Hocoma (DIH Medical), BIOMETRICS LTD., Bionik Laboratories Corp., BioXtreme Ltd., Ekso bionics holdings, Inc., Kinestica, Saebo, Inc., Abbott Laboratories, Emotiv Inc., BrainCo, Inc, Permobil AB, and Medtronic Plc.